IL33 and Miyoshi myopathy: It is conceivable that the decrease in IL-33 determines on the one hand the progression from MGUS to MM and on the other hand weakens the immune response not only towards tumour cells but also towards exogenous antigens, thus contributing to the genesis of secondary immunodeficiency.